Live
AgilentAgilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWSLonza NewsLonza Group AG Stock Faces Pressure Amid Biopharma Sector Slowdown and Capacity Utilization Concerns - AD HOC NEWSCellThe BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic SitesIlluminaSwiss Life Asset Management Ltd Purchases 67,772 Shares of Illumina, Inc. $ILMN - MarketBeatThermo FisherSarasin & Partners LLP Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeatLonza NewsLonza Group AG stock faces pressure amid biotech slowdown as of March 2026 - AD HOC NEWSLonza NewsNature of Things: Lonza, antibodies and Solano County’s biotech future - Daily Republic10x Genomics BlogHow ARK’s TXG Selloff and Cautious 2026 Outlook Will Impact 10x Genomics (TXG) Investors - simplywall.stCellHyperinnervation inhibits organ-level regeneration in mammalian skinCellDeciphering mechanical determinants of morphological evolutionCellAn activated wheat CC<sub>G10</sub>-NLR immune receptor forms an octameric resistosomeCellThe E3-ome gene-centric compendium reveals the human E3 ligase landscape
Thermo Fisher Jan 19, 2026

Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - Yahoo Finance

Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - Yahoo Finance

Original
Body unavailable. Use the original source.

Directory

59 All